Development of 28 public molecular laboratories in France for molecular testing. Development of 28 public molecular laboratories in France for molecular.

Slides:

Advertisements

Similar presentations

The Inflammatory Breast Cancer Cancer Registry Paul H. Levine, M.D. Paul H. Levine, M.D. The George Washington University School of Public Health and Health.

Advertisements

(Adapted and reprinted with permission, from Hughes JM et al: Effect of lung volume on the distribution of pulmonary blood flow in man. Respir Physiol.

A Paradigm Shift From One-Size-Fits-All to Tailor-Made Therapy for Metastatic Colorectal Cancer.

Rearrangements of Gene A and Gene B

Diagnosis of irritable bowel syndrome

Figure 1 Underreporting of treatment-related toxicities by physicians, relative to patients with either advanced-stage lung cancer, or early-stage breast.

Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times

Details and Difficulties Regarding the New Lung Cancer Staging System

Depicted are patient and disease factors used to determine optimal A1C targets. Depicted are patient and disease factors used to determine optimal A1C.

Kaplan–Meier curve for the time until the development of lung cancer in patients with idiopathic pulmonary fibrosis. Kaplan–Meier curve for the time until.

Distribution of lower extremity artery disease (LEAD) Fontaine stages over the combined chronic obstructive pulmonary disease (COPD) Global Initiative.

Kyong-Ah Yoon, Sohee Park, Sang Hee Lee, Jin Hee Kim, Jin Soo Lee

Andrew Narva American Journal of Kidney Diseases

Epidemic of Lung Cancer in Patients With HIV Infection

Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S

Percentage of patients per stage of oesophageal cancers in the two trials, overall difference P

Clinical Characteristics and Outcomes for Patients With Thymic Carcinoma: Evaluation of Masaoka Staging Anya M. Litvak, MD, Kaitlin Woo, MS, Sara Hayes,

Cumulative incidence of (A) ESRD, (B) all-cause death, (C) all-cause death without ESRD and (D) ESRD or all-cause death in patients with T1DM diagnosed.

Distribution of informative SNPs with LOH (black bars) on each chromosome (rows, oriented p-arm at the bottom and q-arm at the top of each chromosome)

3-year survival of lung cancer patients in the general population and in those with a prior diagnosis of chronic obstructive pulmonary disease (COPD).

Volume 2(Supplement 1):46-49

August Heidland, MD, Udo Bahner, MD, Spiros Vamvakas, MD

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

Distribution of patients in the first- or second-year follow-up according to the number of acute exacerbations of chronic obstructive pulmonary disease.

Expression analysis of IGFBP-3 using human whole-genome microarray.

Effect of nucleoside analogues on DNA repair response initiated by 4-HC. Effect of nucleoside analogues on DNA repair response initiated by 4-HC. A, CLL.

Representative examples of estrogen receptor α and β immunohistochemical expression (top figures) and EGFR mutations (bottom figures) in lung adenocarcinomas.

Association between RB pathway alterations and poor prognosis in early-stage lung adenocarcinoma patients. Association between RB pathway alterations and.

Frequent alterations identified and potential actionability.

A, Overall survival of patients treated with CAR T cells (black line; n = 15). A, Overall survival of patients treated with CAR T cells (black line; n.

Effects of maternal exposure during pregnancy to tap water (control), LIM, or HIM on offspring tumor incidence (% rats with tumors; A), tumor multiplicity.

Effect of nicotinamide and carbogen on 5-FU uptake (measured as SUV3

Correlation between serum visfatin concentrations and the clinical stage (A) and tumor size (B, C) of HCCs. A and B, the correlations were determined by.

FGFR3 mutation analysis of a selection of urine samples from patients included with an FGFR3-mutant (MT) tumor. FGFR3 mutation analysis of a selection.

Kaplan-Meier curves for PFS (panel A) and OS (panel B) of patients with mTCC receiving an anti-EGFR based therapy. mTCC, metastatic transverse colon cancer;

Somatic mutational rates and survival analysis of IBD-CRC.

FILM protein signature predicts poor survival in nontreated stage-IB lung adenocarcinoma. FILM protein signature predicts poor survival in nontreated stage-IB.

Molecular signatures are independent of tumor stage and grade.

AMs contribute to the progression of EGFR-mutant lung adenocarcinoma.

New dialysis starts in the United States by year in patients with and without diagnosis of diabetes. New dialysis starts in the United States by year in.

Location of common clinically relevant mutations in EGFR

Survival risk prediction analysis and application of the metastasis gene signature. Survival risk prediction analysis and application of the metastasis.

Kaplan-Meier survival analysis of p53 mutation in the overall breast tumor series. Kaplan-Meier survival analysis of p53 mutation in the overall breast.

Nested RT-PCR of Mammaglobin and CK19 mRNA in plasma and circulating cells of controls (C) and patients (T) with breast cancer. Nested RT-PCR of Mammaglobin.

NKT cell recognition of CD1d1 molecules is inhibited by treatment with ascites. NKT cell recognition of CD1d1 molecules is inhibited by treatment with.

A, Stacked Venn plots of the significantly associated (FDR < 25%) KEGG pathways for 3 imaging subtypes with GSEA. B, Pathway activity scores for 3 imaging.

PSMA expression in pre- and posttreatment prostate carcinoma serum.

Venn diagram for degree of overlap of 158 candidate prognostic genes.

A 63-year-old female with lung adenocarcinoma treated with nivolumab, who experienced pseudoprogression. A 63-year-old female with lung adenocarcinoma.

Influence of ASGR2 expression on survival.

Prevalence of germline T790M.

Location of the ER mutations and frequencies per cohort.

Mean weight change from original weight of (a) BALB/c (b) DBA/2 mice after one (♦) or two (▴) injections of 10 mg/kg and one (▪) or two (×) injections.

Efficacy summary for patients with gastric/GEJ adenocarcinoma (part B)

Association of overall survival and PAP-specific (A, B) and PA2024-specific (C, D) CTL activity at week 26 using categorical (tertile) analysis and continuous.

A, pretreatment CT scan of pelvic lymphadenopathy (identified by white arrow) in 1 patient with documented response to 1α-OH-D2. A, pretreatment CT scan.

Increased frequency and number of KLL-specific clonotypes in tumors is associated with improved MCC-specific survival. Increased frequency and number of.

Mean percentage change from baseline in total IGF-I and the R1507 serum concentration values following a single i.v. administration of R mg/kg (n.

A, Selected 4 quantitative imaging features significantly associated with 3 imaging subtypes, including tumor volume, tumor sphericity, tumor homogeneity.

Molecular definitions of lung adenocarcinoma subtypes.

The best response for target lesions per patient for patients with target lesions assessed at baseline and at least 1 follow-up. The best response for.

HPLC chromatograms using mobile phase containing CTAB and OSA showing complete separation of: A, phthaloylglutamine and phthaloylisoglutamine authentic.

Genetic analysis suggests the presence of four clinically relevant groups of histologically defined anaplastic oligodendrogliomas. Genetic analysis suggests.

Patient stratification using survival risk prediction and BCLC staging

Progression and survival analysis.

Detection of E-cadherin fragments in human prostate cancer metastases.

Biopsies of the vaccination site were obtained 48 h after the first vaccination. Biopsies of the vaccination site were obtained 48 h after the first vaccination.

Regression analysis showing the positive correlation between number of months since the prior chemotherapy regimen (X axis) and the difference between.

Relative frequencies of FGFR aberrations in non–small cell lung carcinoma. Relative frequencies of FGFR aberrations in non–small cell lung carcinoma. A,

Balancing bleeding in brain metastases

Presentation transcript:

Development of 28 public molecular laboratories in France for molecular testing. Development of 28 public molecular laboratories in France for molecular testing. A, the geographical distribution of the 28 laboratories. B, the volume of K-Ras and EGFR tests done in the laboratories. In B, the incidence is the overall number of cases per year, regardless of stage, and the number of patients who should be tested is an approximate evaluation of patients who are presenting with a metastatic disease. This approximate evaluation may explain why the actual number of patients tested is higher for lung cancers. Adapted from the French NCI Scientific Report 2010–2011 with permission from the Institut National du Cancer (15). Fabrice Andre et al. Clin Cancer Res 2012;18:1555-1560 ©2012 by American Association for Cancer Research